Remote monitoring cost-effective for heart failure patients with implantable defibrillators

Remote management of heart failure patients with implantable defibrillators appears to be cost-effective compared to the conventional method of in-person evaluations, finds an article in the Journal of Medical Internet Research.

"Heart failure patients with implantable defibrillators place a significant burden on healthcare systems," states the article. "Remote monitoring allows assessment of device function and heart failure parameters, and may represent a safe, effective, and cost-saving method compared to conventional in-office follow-up."

The article summarizes the economic evaluation of the Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) study, a multicenter clinical trial aimed at measuring the benefits of remote monitoring for heart failure patients with implantable defibrillators. In the study, 200 patients implanted with a wireless transmission-enabled implantable defibrillator were randomized to receive either remote monitoring or the conventional method of in-person evaluations. 

These patients were followed for 16 months with a protocol of scheduled in-office and remote follow-ups. The economic evaluation of the intervention was conducted from the perspectives of the healthcare system and the patient. 

"Results from the cost-utility analysis of the EVOLVO study show that remote monitoring is a cost-effective and dominant solution," concludes the article.

Overall, remote monitoring did not show significant annual cost savings for the healthcare system, according to the article. In addition, there was a significant reduction of the annual cost for the patients in the remote arm in comparison to the standard arm, based on the results. 

In related news, Indianapolis-based St. Vincent Health partnered with its parent organization, Ascension Health Alliance, in a joint venture to officially launch a remote care management program with the goal of scaling the program on a national level. A 2010 federally-funded ARRA Beacon Community Grant study wrapped up in December 2012, successfully demonstrating that remote monitoring reduced the 30-day readmission rate for patients discharged with congestive heart failure and chronic obstructive pulmonary disease.

To learn more:
- read the article

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.